January 24, 2018
Foundation Fighting Blindness will present its Visionary Award to Richard J. Mark, chairman and president of Ameren Illinois, and Chris Zimmerman, president and CEO of Business Operations of the St. Louis Blues, at its 9th Annual St. Louis Dining in the Dark Visionary Awards Dinner.
January 15, 2018
Foundation Fighting Blindness' Dr. Stephen Rose comments on the announcement of the FDA approval of LUXTURNA™ gene therapy for inherited blindness due to mutations in the RPE65 gene in an interview with MedicalResearch.com.
December 31, 2017
Jenny Schisler writes about her experiences dealing with a family diagnosed with retinitis pigmentosa and how getting involved with organizations like the Foundation Fighting Blindness help.
December 01, 2017
Benjamin Yerxa, PhD, recently appointed CEO of the Foundation Fighting Blindness, aims to expand relationships with the financial community to facilitate research into new science and potential therapies for inherited retinal diseases.
November 29, 2017
After meeting researchers at a Foundation Fighting Blindness event, Christian Guardino bravely participated in a clinical trial at the age of 13 that improved his vision.
November 25, 2017
Nearly three months after receiving an artificial retina, Linda Kirk is beginning to see the world around her for the first time in 50 years.
November 14, 2017
Foundation Fighting Blindness CEO Benjamin Yerxa, PhD., comments on the ProQR clinical trial for children and adults with Leber’s congenital amaurosis 10.
November 10, 2017
What makes a philanthropist? The attributes are many, a new study shows. Read Gordon Gund's feature in The New York Times.
November 07, 2017
Foundation Fighting Blindness' Dr. Stephen Rose discusses the FDA advisory panel recommended approval of Spark Therapeutics’ Gene Therapy Luxturna with MedicalResearch.com.
November 01, 2017
In a blog written by Kevin McCormack, he heard Janni Lehrer-Stein, who was just 26 when she was diagnosed with a degenerative eye disease, speak at a FFB event.